NDC 53002-1631

Reclipsen 28 Day

Desogestrel And Ethinyl Estradiol

Reclipsen 28 Day is a Kit in the Human Prescription Drug category. It is labeled and distributed by Rpk Pharmaceuticals, Inc.. The primary component is .

Product ID53002-1631_1896dd64-259b-4e4c-a17e-1fb9d409aa62
NDC53002-1631
Product TypeHuman Prescription Drug
Proprietary NameReclipsen 28 Day
Generic NameDesogestrel And Ethinyl Estradiol
Dosage FormKit
Marketing Start Date2017-01-01
Marketing CategoryANDA / ANDA
Application NumberANDA075256
Labeler NameRPK Pharmaceuticals, Inc.
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 53002-1631-1

1 BLISTER PACK in 1 PACKAGE (53002-1631-1) > 1 KIT in 1 BLISTER PACK
Marketing Start Date2017-09-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 53002-1631-3 [53002163103]

Reclipsen 28 Day KIT
Marketing CategoryANDA
Application NumberANDA075256
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-09-01
Inactivation Date2020-01-31

NDC 53002-1631-1 [53002163101]

Reclipsen 28 Day KIT
Marketing CategoryANDA
Application NumberANDA075256
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-09-01
Inactivation Date2020-01-31

NDC 53002-1631-6 [53002163106]

Reclipsen 28 Day KIT
Marketing CategoryANDA
Application NumberANDA075256
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-09-01
Inactivation Date2020-01-31

Drug Details

OpenFDA Data

SPL SET ID:94c569ae-e08b-473d-9653-eff044354deb
Manufacturer
RxNorm Concept Unique ID - RxCUI
  • 748797
  • 749848
  • 240707
  • 753543

    • NDC Crossover Matching brand name "Reclipsen 28 Day" or generic name "Desogestrel And Ethinyl Estradiol"

    NDCBrand NameGeneric Name
    0555-9043ApriDesogestrel and Ethinyl Estradiol
    50090-2481ApriDesogestrel and Ethinyl Estradiol
    51862-238CaziantDesogestrel and Ethinyl Estradiol
    53002-1628CaziantDesogestrel and Ethinyl Estradiol
    50102-154CYREDdesogestrel and ethinyl estradiol
    53002-1722CYREDdesogestrel and ethinyl estradiol
    50102-254Cyred EQDesogestrel and Ethinyl Estradiol
    53002-2722Cyred EQDesogestrel and Ethinyl Estradiol
    0378-7282DESOGESTREL AND ETHINYL ESTRADIOLdesogestrel and ethinyl estradiol
    51862-514Desogestrel and Ethinyl EstradiolDesogestrel and Ethinyl Estradiol
    0254-2033EMOQUETTEdesogestrel and ethinyl estradiol
    0603-7540Emoquettedesogestrel and ethinyl estradiol
    53002-1646Emoquettedesogestrel and ethinyl estradiol
    57297-882ENSKYCEdesogestrel and ethinyl estradiol
    0781-4066Isibloomdesogestrel and ethinyl estradiol
    63629-2333Isibloomdesogestrel and ethinyl estradiol
    16714-464JuleberDesogestrel and Ethinyl Estradiol
    65862-887KalligaDesogestrel and Ethinyl Estradiol
    0603-7512Kimidessdesogestrel and ethinyl estradiol
    0093-3304ReclipsenDesogestrel and Ethinyl Estradiol
    53002-1631ReclipsenDesogestrel and Ethinyl Estradiol
    0555-9051VelivetDesogestrel and Ethinyl Estradiol
    53002-1775VelivetDesogestrel and Ethinyl Estradiol
    63629-2449VolneaDesogestrel and Ethinyl Estradiol

    Trademark Results [Reclipsen]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    RECLIPSEN
    RECLIPSEN
    78543779 3225685 Live/Registered
    ACTAVIS HOLDCO US, INC.
    2005-01-07
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.